Introduction
============

Hydrogen sulfide, a "superstar" gasotransmitter in the gaseous signal molecule family, has been found involved in various physiologic and pathophysiologic processes since the end of the last century. The role of H~2~S in the nervous, cardiovascular, digestive, and respiratory systems was examined, and the existence of endogenous H~2~S was verified. To understand how endogenous H~2~S regulates various cellular processes, researchers identified that H~2~S was involved in a post-translational modification, called *S*-sulfhydration, of a large number of proteins ([@B49]; [@B57]). A variety of key proteins of different cellular pathways in mammals are sulfhydrated by H~2~S to regulate and affect the processes of cell survival/death, cell differentiation, cell proliferation/hypertrophy, cellular metabolism, mitochondrial bioenergetics/biogenesis, ER stress, vasorelaxtion, inflammation, oxidative stress, for example.

This review summarizes recent studies of H~2~S-induced sulfhydration as a post-translational modification that plays vital roles in diverse physiologic and pathophysiologic processes. Additionally, we discuss methods to detect sulfhydration of proteins.

Properties of H~2~S and *S*-Sulfhydration, and Formation Process of *S*-Sulfhydration
=====================================================================================

H~2~S has some properties different from other gasotransmitters. The most typical difference is its dissociation ability. Its pKa is 6.77; under normal conditions, such as aqueous solutions at pH 7.4, over three quarters of H~2~S are dissociated to HS-anion and only 20% not dissociated, even though the concentration of S^2-^ is critically low. The H~2~S pool is believed to consist of H~2~S, HS^-^ and S^2-^. Protein persulfidation, or protein *S*-sulfhydration is regarded as one of the important molecular mechanisms by which H~2~S plays various biological effects. More accurately, this difference is mainly reflected in the modification of cysteine residues from the -SH to -SSH group. The -SH and -SSH groups differ significantly in properties. As compared with corresponding thiols (-SH), hydropersulfides (-SSH) have a stronger nucleophilic ability, for greater chemical reactivity. When pH is under physiological conditions, because of the lower pKa, hydropersulfides exhibit stronger acidity and will become more active hydrogen donors then thiols ([@B57]). Another significant difference is the bond dissociation energy of S-H in RSSH or RSH: the former is 70 kcal/mol and the latter is 92 kcal/mol ([@B6]). Therefore, perthiyl radicals (RSS •) are more stable than thiyl radicals (RS •) which can be a very efficient antioxidant stress factor.

In recent years, the interests of people on the biological function of sulfhydrated protein has been growing ceaselessly, but the number of the research which addressed on mechanism for the formation process of sulfhydrated proteins is still small. Here we showed some main formation processes of *S*-sulfhydrated modification which is believed to occur possibly in the following cases: (1) although protein thiols do not react with H~2~S directly, it can react with sulfenic acids; (2) H~2~S can react with *S*-nitrosated cysteines leading to the formation of HSNO or nitroxyl (HNO); (3) H~2~S can react with cysteine disulfides (-S-S) for sulfhydration formation; (4) reaction between oxidized sulfide species such as polysulfides and cysteine thiols; (5) persulfides play as carriers and engage in "*trans-S*-sulfhydration" reaction (**Figure [1](#F1){ref-type="fig"}**).

![The mainly proposed formation processes for sulfhydrated proteins. **(A)** H~2~S can not react with protein thiols directly; **(B)** H~2~S can react with sulfenic acids for sulfhydration formation; **(C)** H~2~S can react with *S*-nitrosated for sulfhydration formation depending on the environment; **(D)** H~2~S reacts with cysteine disulfides (-S-S) for sulfhydration formation; **(E,F)** Persulfides can be a carrier of sulfhydration and act as the processes of displacement reaction.](fphar-08-00608-g001){#F1}

Sulfhydration Mediates H~2~S-Induced Biological Function
========================================================

*S*-sulfhydrated modification as a new post-translational modification is involved in many physiological and pathological processes. After *S*-sulfhydrated, proteins would change their original function, serving as important switchers or regulators. We summarize some literatures on *S*-sulfhydrated modification targets in recent years and elucidate the important biological function of sulfhydration modification in many physiological and pathophysiological processes (**Figure [2](#F2){ref-type="fig"}** and **Table [1](#T1){ref-type="table"}**).

![The biological functions of *S*-sulfhydration by H~2~S. → means stimulating effect, whereas ⊣ means inhibitory effect.](fphar-08-00608-g002){#F2}

###### 

Examples of sulfhydrated proteins listed in alphabetical order.

  Protein modified           Sites             Protein activity   Functions                                                                                                                       Reference
  -------------------------- ----------------- ------------------ ------------------------------------------------------------------------------------------------------------------------------- -----------
  AR                         C611, C614        ↓                  Inhibits AR-DNA binding activity and AR dimerization, therefore suppresses proliferation of prostate cancer cells               [@B91]
  ATP5A1                     C244, C294        ↑                  Maintains ATP synthase in a physiologically activated state, supporting mitochondrial bioenergetics                             [@B48]
  Caspase 3                  C163              ↓                  Prevents against neuronal ischemic/reperfusion injury                                                                           [@B46]
  eNOS                       C443              ↑                  Promotes eNOS phosphorylation, inhibits its S-nitrosylation and increases eNOS dimerization                                     [@B1]
  GAPDH                      C150              ↑                  N/A                                                                                                                             [@B49]
                             C156, C152        ↓                  N/A                                                                                                                             [@B32]
  GATA3                      C84/182,C84/248   ↓                  Controls the differentiation of splenocytes and regulates the developments of allergic asthma                                   [@B73]
  IRF-1                      C53               ↑                  Maintains mitochondrial DNA replication                                                                                         [@B40]
  Keap1                      C151              ↓                  Activates Nrf2 signaling, attenuates oxidative stress and delays cellular aging in mouse embryonic fibroblasts                  [@B84]
                             C151              ↓                  Activates Nrf2 signaling, and attenuates oxidative stress induced by high glucose plus ox-LDL in macrophage                     [@B80]
                             C226, C613        ↓                  Activates Nrf2 signaling, protects cells from oxidative stress                                                                  [@B29]
  Kir6.1 subunit of K~ATP~   C43               ↑                  Mediates the cholinergic vasorelaxation and hyperpolarization                                                                   [@B50]
  LDHA                       C163              ↑                  Stimulates mitochondrial respiration of the colon cancer line HCT116 and promote cell proliferation                             [@B68]
  MEK1                       C341              ↑                  Facilitates the translocation of phosphorylated ERK into nucleus, activates PARP-1, and then increases the DNA damage repair    [@B90]
  p65 subunit of NF-κB       C38               ↑                  Suppresses apoptosis induced by TNF-α in liver and macrophage physiologically                                                   [@B60]
                                               ↓                  Inhibits ox-LDL-induced macrophage inflammation                                                                                 [@B17]
  p66Shc                     C59               ↓                  Inhibits H~2~O~2~ -induced mitochondrial reactive oxygen species production                                                     [@B82]
  Parkin                     C59, C95, C182    ↑                  Enhances ubiquitination in the neuron cell lines and reduces cell death in the Parkinson disease's cell model                   [@B70]
  PC                         C265              ↑                  Stimulates gluconeogenesis                                                                                                      [@B35]
  PTEN                       C71, C124         ↑                  Inhibits the *S*-nitrosylation of PTEN                                                                                          [@B54]
  PTP1B                      C215              ↓                  Inhibits the dephosphorylation of PERK, and then promotes PERK activation during the response to endoplasmic reticulum stress   [@B39]
  PP1c                       C127              ↓                  Increases the phosphorylation of eIFα and induces a transient adaptive reprogramming of global mRNA translation                 [@B83]
  PPARγ                      C139              ↑                  Increases glucose uptake and lipid storage in adipocyte                                                                         [@B8]
  RAGE                       C259, C301        ↓                  Prevents the neural cell against RAGE-mediated pathological effects including oxidative stress and aging                        [@B94]
  Runx2                      C123, C132        ↑                  Promotes osteoblast differentiation and maturation                                                                              [@B93]
  Sp1                        C68, C755         ↑                  Upregulates expression of VEGFR-2 and neuropilin-1, thereby enhances VEGF-induced endothelial responses                         [@B58]
                             C664              ↓                  Suppress expression and activity of KLF5, thereby prevents myocardial hypertrophy                                               [@B47]
  SUR1 subunit of K~ATP~     C6, C26           ↑                  Activates K~ATP~ channel                                                                                                        [@B33]
  SUR2B subunit of K~ATP~    C24, C1455        ↑                  Reduces the tyrosine nitration of Kir6.1                                                                                        [@B37]
  TRPV6                      C172, C329        ↑                  Induces Ca^2+^ influx in BMMSCs, and maintains BMMSC self renewal and osteogenic differentiation                                [@B43]
                                                                                                                                                                                                  

Effect of

S

-sulfhydration on the activity of different proteins and come-off. ↑ Denotes activation, ↓ denotes restrain, N/A denotes not mentioned. This table does not include the target protein in which specific sulfhydrated cysteine is not demonstrated. AR, androgen receptor; ATP5A1, α-subunit of ATP synthase; eNOS, endothelial NO synthase; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; GATA3, GATA binding protein 3; IRF-1, Interferon regulatory factor 1; Keap1, Kelch-like ECH-associated protein 1; Nrf2, transcription factor nuclear factor erythroid 2--related factor 2; ox-LDL, oxidized low-density lipoprotein; K

ATP

, ATP sensitive potassium channel; LDHA, lactate dehydrogenase a; MEK1, map kinase kinase; ERK, extracellular signal regulated kinase; PARP-1, poly(ADP-ribose)polymerase-1; NF-κB, nuclear factor-κB; PC, pyruvate carboxylase; PTEN, phosphatase and tensin homolog deleted on chromosome ten; PTP1B, protein tyrosine phosphatase 1B; PP1c, Protein phosphatase-1; PPARγ, peroxisome proliferator-activated receptor γ; RAGE, receptor for advanced glycation endproducts; Runx2, runt-related transcription factor 2; Sp1, specificity protein 1; VEGFR, receptor of vascular endothelial growth factor; KLF5, Krüppel-like factor 5; SUR, sulfonylurea receptor; TRPV6, transient receptor potential cation channel subfamily V member 6; BMMSC, bone marrow mesenchymal stem cells.

*S*-Sulfhydration and Cell Survival/Death
-----------------------------------------

Apoptosis or programmed cell death is a physiological process that is highly regulated by cells or tissues themselves for various biological processes. GAPDH is among the first proteins found to be modified by *S*-sulfhydration in the history of post-translational modification by H~2~S ([@B49]). It plays a significant role in regulating both cell survival and apoptotic death ([@B15]; [@B53]). GAPDH is an important redox-sensitive protein, the activity of which is largely affected by its highly reactive cysteine residue (Cys). The change in cysteine thiol helps GAPDH translate to the nucleus, where it promotes the degradation of nucleoproteins, inducing cell apoptosis ([@B27]). [@B49] showed that H~2~S could uniquely *S*-sulfhydrate GAPDH at Cys150 under physiological conditions, thereby enhancing GAPDH catalytic activity. The results *in vivo* also showed that GAPDH activity was reduced by 25--30% in CSE^-/-^ mice compared with the wild type mice ([@B49]). Another group also confirmed that GAPDH could be *S*-sulfhydrated by endogenous H~2~S ([@B88]). On the contrary, [@B32] discovered that polysulfides inactivated the reduced purified GAPDH by 42% through *S*-sulfhydration on the Cys156. Moreover, polysulfides further decreased the activity of C156S mutant GAPDH via *S*-sulfhydration on the Cys 152, suggesting *S*-sulfhydration on the Cys 156 and Cys 152 inactivated GAPDH ([@B32]). Thus, modification of *S*-sulfydration may regulate GAPDH function, which controls cell apoptosis.

The DNA damage repair is an important response to maintain genomic stability, which is the basis for normal cell development and functions. Poly(ADP-ribose)ation mediated by PARPs is one of the important cellular responses to DNA damage ([@B3]). [@B90] found that H~2~S activated PARP1 and prevented DNA damage in endothelial cells and fibroblast. The protective effect of H~2~S involved ERK phosphorylation and nuclear translocation followed *S*-sulfhydrating map kinase kinase 1 (MEK1) at cysteine 341 ([@B90]). Mutation of cysteine 341 in MEK1 blocked the H~2~S-induced PARP1 activation, which further supported the major role of H~2~S *S*-sulfhydration in the DNA damage repair.

*S*-sulfhydrations of nuclear factor-κB (NF-κB) p65, parkin and caspase 3 were also involved in the anti-apoptotic/pro-survival effects of H~2~S. [@B60] demonstrated that H~2~S could modify NF-κB p65 at Cys 38 thiol, enhance the binding of sulfhydrated p65 to its co-activator ribosomal protein S3, and promote the transcription of anti-apoptotic genes such as Bcl-XL and cIAP2. In cystathionine γ- lyase knock out (CSE^-/-^) mice, anti-apoptotic function and *S*-sulfhydration of NF-κB was significantly abolished, which strengthened the pro-survival role of H~2~S ([@B60]). Parkin is an E3 ubiquitin ligase which participated in the regulation of protein degradation and exerted an important neuroprotective effect. [@B70] revealed that H~2~S enhanced parkin activity via sulfhydration on the Cys59, Cys95 and Cys182 sites, and then prevented cell death in the cellular models of PD. Furthermore, a marked decrease in the parkin sulfhydration in PD brain was observed, suggesting that sulfhydration of parkin is essential for neuron survival ([@B70]). [@B46] found that thiosulfate, an oxidation product of H~2~S, directly inhibited caspase 3 activity through sulfhydration at Cys163, decreased neuronal cell apoptosis, and therefore prevented against neuronal ischemic/reperfusion injury.

*S*-Sulfhydration and Cell Differentiation
------------------------------------------

Differentiation from multipotent stem cell to terminal tissue-specific cell is important for the physiological development and pathophysiological tissue repair. In the previous studies, H~2~S was reported to regulate the differentiation of BMMSCs, periodontal ligament stem cells, neural stem cells, osteoclast and osteoblast ([@B75]; [@B23]; [@B43]; [@B63]; [@B93]). The mechanisms involved the control of Ca^2+^ transient receptor potential cation channels, PKC/ERK-mediated Wnt/β-catenin signaling, ERK, Nrf2, Akt and Runx2 pathways by H~2~S. Liu et al found that H~2~S could sulfhydrate TRPV6 at Cys172 and Cys329 in the BMMSC, induce Ca^2+^ influx in BMMSCs, and maintain BMMSC self renewal and osteogenic differentiation. Simultaneously, sulfhydration of TRPV3 at Cys131 and sulfhydration of TRPM4 at Cys168 might be also involved in the regulatory effect of H~2~S on the osteogenic differentiation ([@B43]). [@B93] demonstrated that H~2~S promoted osteoblast differentiation and maturation through sulfhyating Runx2 at Cys 123 and Cys 132, which caused transactivation of Runx2.

In addition to the differentiation of stem cells, the differentiation of naïve immune cells is also important for the body homeostasis. GATA-3 is a transcription factor which controls the differentiation of naïve immune cells, demonstrated by inducing Th0 cell differentiation toward Th2 cell subtype, and promotes type-2 immune response. Wang et al found that H~2~S inhibited the transcriptional activity of GATA-3 through sulfhydrating its Cys84/182 or Cys84/248 sites, promoted the splenocyte differentiation of protective type-1 cytokine-generating cells and suppressed their differentiation toward type-2 cytokine-generating cells. Therefore, age-dependent endogenous H~2~S generation was correlated with the development of airway inflammation in the allergic asthma ([@B73]).

*S*-Sulfhydration and Cell Proliferation/Hypertrophy
----------------------------------------------------

Excessive proliferation is the main feature of neoplastic disease. Modulatory effect of H~2~S on the tumor cell proliferation is different depending on tumor types. [@B91] found that CSE expression was decreased in both LNCaP-B and prostate cancer tissues. H~2~S inhibited cell proliferation of both LNCaP and LNCaP-B. Moreover, forced expression of CSE restored the sensitivity of LNCaP-B cells to androgen antagonists. Mechanistically, they demonstrated that AR mediated the abovementioned effect of H~2~S evidenced by the facts that H~2~S sulfhydrated AR at Cys 611 and 614, destroyed the functional zinc finger structure in the AR, then inhibited the transcriptional activity of AR, and accordingly suppressed the proliferation of prostate cancer ([@B91]). On the contrary, [@B68] revealed that endogenous H~2~S production and expression of its generating enzyme CBS in colon cancer cells were upregulated. H~2~S promoted the proliferation of colon cancer cell HCT116 via sulfhydrating LDHA at Cys163 to enhance its activity.

Inadequate proliferation of endothelial cell is one of the vital characterizations of endothelial dysfunction, which resulted in vascular injury diseases. [@B58] found that cystathionine β-synthase (CBS)-derived H~2~S maintained the VEGF-dependent cellular response including VEGF-dependent proliferation resulting from increased VEGFR-2 and neuropilin-1 expression in endothelial cell, mediated by the *S*-sulfhydration of the transcription factor Sp1 at residues Cys68 and Cys755 and therefore enhanced the transcriptional activity of Sp1 ([@B58]). This study confirmed the deficiency of CBS/H~2~S-mediated protein *S*-sulfhydration in the development of vascular dysfunction.

Myocardial hypertrophy is a major adaptive response of cardiomyocyte when it meets various stimulators. The KLF5 was an important signaling contributed to the development of cardiac hypertrophy induced by angiotensin II ([@B62]). [@B47] found that H~2~S donor GYY4137 decreased KLF5 promoter activity, reduced KLF5 mRNA expression, inhibited transcriptional activity of KLF5, and therefore prevented cardiomyocyte hypertrophy *in vitro* and *in vivo*. The above effects of H~2~S were mediated by its sulfhydration of Sp1 at Cys664 to block the binding of Sp1 to the KLF5 promoter ([@B47]).

*S*-Sulfhydration and Cellular Metabolism
-----------------------------------------

More and more studies confirmed that H~2~S acted as an important regulator of lipid and glucose metabolism. It was reported that H~2~S modulated the adipogenesis, lipolysis, apolipoprotein biosynthesis, glucose utilization, glucogenesis, and insulin resistance, etc. The impairment of endogenous H~2~S generation and function was the important pathogenesis of dyslipidemia and/or hyperglycemia-related diseases. Cai et al found that H~2~S promoted the triglyceride accumulation in adipocyte differentiation, increased the adipocyte number in mice fed with a high-fat diet for 4 weeks and alleviated insulin resistance of adipose tissues but did not increase the obesity of mice fed with high-fat diet for 13 weeks simultaneously. The mechanism by which H~2~S changed glucose into triglyceride storage in adipocytes was associated with the facts that H~2~S induced *S*-sulfhydration of PPARγ at Cys 139, increased its nuclear translocation and DNA binding activity, and promoted adipogenesis gene expression ([@B8]). [@B35] explored the role of *S*-sulfhydration modified by CSE-derived H~2~S in the regulation of glucogenesis. The data showed that H~2~S donor or overexpression of CSE induced PC sulfhydration, enhanced PC activity, therefore promoted glucose production in liver cells. Furthermore, site-directed mutation at Cys 265 blocked H~2~S-induced PC sulfhydration and activity ([@B35]). Additionally, sulfhydration of peroxisome proliferator-activated receptor-γ coactivator-1α, fructose-1,6-bisphosphatase and glucose-6-phosphatase was also involved in the regulation of hepatic glucose production ([@B69]).

*S*-Sulfhydration and Mitochondrial Bioenergetics/Biogenesis
------------------------------------------------------------

The steady state of mitochondria is very important during a cell life and is often metobolism-related, including ATP synthesis and processes that regulate cell growth and death. In the last few years, increasing evidence showed that H~2~S could stimulate mitochondrial bioenergetics and act as a mitochondrial protectant ([@B34]; [@B4]). PPARγ coactivator-related protein (PPRC) has positive effect in maintaining the stability of cell energy metabolism and normal cell viability. PPRC could be *S*-sulfhydrated by H~2~S, and the level was lower in untreated CSE--knockout hepatocytes, which regulated cell energy homeostasis under physiological conditions as well as mitochondrial bioenergetics ([@B67]). H~2~S can also induce a *S*-sulfydration of α subunit of ATP synthase (ATP5A1) at Cys244 and Cys294, which maintains ATP synthase activation under physiological condition, thereby supporting mitochondrial bioenergetics ([@B48]). Li and colleagues confirmed the role of H~2~S in maintaining mitochondrial DNA replication and mitochondrial marker gene expression. They revealed that H~2~S sulfhydrated IRF-1 at Cys 53, enhanced its binding with the Dnmt3a promoter, reduced Dnmt3a expression, and induced mitochondrial transcription factor A promoter demethylation and therefore promoted mitochondrial DNA replication ([@B40]).

*S*-Sulfhydration and Endoplasmic Reticulum Stress (ERS)
--------------------------------------------------------

Endoplasmic reticulum is composed of a membrane in eukaryotic cells and an important organelle for protein synthesis, folding and secretion. External or internal environment changes will lead to ERS. The PTP family is widely recognized as a group of fundamental enzymes that control various biological processes, such as cell--cell communication, cell growth, division and differentiation ([@B59]). PTP-1B is a vital member of the PTPs protein family; it locates in the cytoplasmic face of ER and plays a key role in ER signaling ([@B5]). PTP-1B loses its enzymatic activity when H~2~S S-sulfhydrates its active-site Cys215 residue both *in vivo* and *in vitro*, thereby promoting the activity of protein kinase RNA-like ER kinase and restoration of ER homeostasis during the response to ERS ([@B39]). Phosphorylation of eIF2α, resulting in inhibition of global protein synthesis, is one of the key biochemical steps for ERS. Yadav et al found that H~2~S could inhibit PP1c via sulfhydration at Cys127, block the dephosphylation of eIF2α and therefore regulate the ERS ([@B83]). Some new pathways by which H~2~S controls ERS have been recently disclosed, including Akt-heat shock protein 90 pathway ([@B81]), brain-derived neurotrophic factor-TrkB pathway ([@B78]), silent mating type information regulator 2 homolog 1 ([@B41]), and Src pathway ([@B85]), etc. However, most of these studies focused on turnon/off of the protein but not the *S*-sulfhydrated protein, nor the specific cysteine affected by H~2~S stimulation. Therefore, further studies are needed to elaborate the mechanism by which H~2~S inhibits ERS.

S-Sulfhydration and Vasorelaxtion
---------------------------------

As one of the important biological functions induced by H~2~S, vasorelaxation of H~2~S and its mechanisms have been extensively studied ([@B28]). A series of target proteins including ion channels and second messengers were found to be involved in the control of vessel tone by H~2~S. Since *S*-sulfhydration was demonstrated, the molecular mechanisms responsible for H~2~S-induced vasodilation were understood significantly. K~ATP~ are composed of pore-forming subunits and regulatory subunits, including Kir6.x (Kir6.1 or Kir6.2), and SURx (SUR1, SUR2A or SUR2B), which mediated the H~2~S-induced vasorelaxation in aorta and mesenteric artery ([@B92]; [@B13]). [@B33] found that Cys6 and Cys26 in the extracellular loop of rat vascular SUR1(rvSUR1) were target of H~2~S-induced *S*-sulfhydration. H~2~S opened the K~ATP~ channel to exert a vasorelaxation via *S*-sulfhydration of K~ATP~ channel ([@B33]), while a research by Mustafa and colleagues revealed that H~2~S induced hyperpolarization in endothelial cells mediated by the opening of Kir 6.1 subunit of K~ATP~ channel via its sulfhydration at Cys43 ([@B50]). Additionally, *S*-sulfhydration of endothelial intermediate conductance potassium channel, small conductance potassium channel and TRPV4 might be in part due to vascular relaxation induced by H~2~S ([@B50]; [@B52]). Sun et al found that H~2~S could increase intracellular cGMP level via sulfhydrate phosphodiesterase 5A to inhibit the cGMP degradation ([@B65]). Moreover, [@B86] demonstrated that *S*-sulfhydration of TRPV1 by CBS-derived H~2~S in carotid sinus facilitated carotid sinus baroreceptor sensitivity to participated the control of blood pressure.

S-Sulfhydration and Inflammation
--------------------------------

The relationship between H~2~S and inflammation is complex. The anti-inflammatory effect of H~2~S was reported in carrageenan-induced paw edema ([@B87]), colitis ([@B19]; [@B72]), synovitis ([@B18]), monoarthritis ([@B2]), atherosclerosis ([@B74]), ischemia-reperfusion injury ([@B95]), cigarette smoke-induced pulmonary injury ([@B11]; [@B26]) and diabetic wound healing ([@B89]), etc. NF-κB signaling is widely known as an important pathway in regulating inflammatory response. [@B17] found that H~2~S inhibited macrophage inflammation induced by oxidized low-density lipoprotein via the sulfhydration of NF-κB p65 at Cys38, thereby restraining NF-κB p65 phosphorylation, nuclear translocation, DNA binding activity and the recruitment to monocyte chemotactic protein-1 promoter. In an experimental model of colitis, endogenous H~2~S synthesis was upregulated and played a protective role due to the activation of K~ATP~ via the *S*-sulfhydration of its subunit SUR2B ([@B72]; [@B22]). In addition to the abovementioned target proteins, there are many other proteins or pathways involved in the anti-inflammatory effect of H~2~S. However, whether H~2~S sulfhydrates those proteins to inhibit the inflammatory response remains unclear.

On the other hand, [@B7] demonstrated that the treatment with DL-propargylglycine, a CSE inhibitor, significantly reduced the severity of pancreatitis and lung injury induced by caerulein. Similarly, in caecal-ligation and puncture-induced sepsis mice model, CSE gene deletion alleviated the liver and lung injury and reduced inflammation along with the activation of ERK1/2 and NF-κB pathway ([@B21]). Those results suggested that H~2~S played a role as pro-inflammatory cytokines. Whether H~2~S is an anti-inflammatory or pro-inflammatory agent is controversial ([@B79]). Therefore, more in-depth studies are needed for broader conclusive answers to elaborate the relationship between H~2~S and inflammation ([@B71]).

*S*-Sulfhydration and Oxidative Stress
--------------------------------------

Numerous experimental results show that the oxidative stress sensor protein Keap1 and Nrf2 are closely related to the oxidative stress injury and the antioxidant response ([@B66]; [@B76]). Previous studies suggested that H~2~S played an important role in protecting against oxidative stress by enhancing Nrf2 nuclear translocation and initiating antioxidant response in ischemia-reperfusion injury ([@B9]; [@B25]; [@B61]), diabetes-accelerated atherosclerosis ([@B80]) and high salt-induced renal injury ([@B30]). Moreover, Nrf2 activation mediated the inhibitory effect of H~2~S on the oxidative stress-induced cell senescence ([@B84]). Regarding the molecular mechanism by which H~2~S activated Nrf2-initiating antioxidant response, [@B84] and [@B80] elucidated that NaHS could *S*-sulfhydrate Keap1 at Cys151, which promoted the dissociation of Nrf2 from Keap1, while [@B29] found that H~2~S inactivated Keap1 through sulfhydrating Keap1 at Cys226/613 site.

P66Shc, an upstream activator of mitochondrial redox signaling, plays a pivotal role in the regulation of intercellular redox homeostasis. Phosphorylation of p66Shc at Ser36 was regarded as a key step to fire the reactive oxidative species production. [@B82] discovered that H~2~S could sulfhydrate p66Shc at Cys59 to inhibit p66Shc phosphorylation, reduce its translocation to mitochondria, block the mitochondrial reactive oxidative species production, and thereby protect neuronal cells against oxidative stress-induced injury. Activation of the RAGE is the key element in the development of the chronic oxidative stress-induced cytotoxicity. Zhou et al found that the treatment of NaHS reduced H~2~O~2~ --induced RAGE dimerization, shortened the half-life of RAGE, decreased the plasma membrane abundance of RAGE and therefore prevented neuron SH-SY5Y cells from cytotoxicity. Mechanistically, cys259 and cys310, which mediated the formation of intermolecular disulfide bond in the RAGE, were verified to be the direct target sites of H~2~S *S*-sulfhydration ([@B94]). Those abovementioned studies are important for better determining the mechanism by which H~2~S exerts the protective role in the oxidative stress-induced diseases.

*S*-Sulfhydration and Other Post-translational Modification
-----------------------------------------------------------

The relationship of *S*-sulfhydration and phosphorylation: [@B82] and [@B17] found that H~2~S-induced *S*-sulfhydration could inhibit phosphorylation of p66Shc and NF-κB p65, and decreased their activity. On the contrary, [@B1] found that H~2~S enhanced eNOS activity by promoting phosphylation of eNOS, which resulted from H~2~S-induced *S*-sulfhydation of eNOS at Cys 443.

The relationship of *S*-sulfhydration and *S*-nitrosylation: For a long period, researches have established that nitric oxide (NO) can act as an important regulator in diverse cell signaling pathway via *S*-nitrosylation happened at cysteine residue of target protein ([@B31]). Under basal conditions, 10--25% of proteins in liver total proteins were *S*-sulfhydrated, while 1--2% of proteins were *S*-nitrosylated ([@B31]; [@B49]). They have some similar chemical properties. For example, it was proposed that the two modifications preferentially occured at low pKa Cys residues of the protein ([@B45]). Many proteins have been confirmed to be controlled by both *S*-nitrosylation and *S*-sulfhydration such as GAPDH, parkin, eNOS, PPARγ, PTP1B, PTEN, p65, SUB2B and etc ([@B14]; [@B27]; [@B12]; [@B49]; [@B70]; [@B1]; [@B10]; [@B54]; [@B8]). In most cases, *S*-sulfhydration and *S*-nitrosylation exert opposite effects. For instance, the glycolytic activity of GAPDH is inhibited by *S*-nitrosylation ([@B27]), whereas *S*-sulfhydration increases its activity about sevenfold ([@B49]). Parkin activity is decreased when *S*-nitrosylated ([@B14]) but increased when *S*-sulfhydrated ([@B70]). *S*-nitrosylation of PPARγ at Cys139 inhibits PPARγ transcription activity ([@B10]), but *S*-sulfhydration of PPARγ at the same residue enhances its activity ([@B8]). Similarly, *S*-nitrosylation of PTP1B at Cys 215 prevents it from H~2~O~2~-induced inactivation ([@B12]), but *S*-sulfhydration of PPARγ at the same residue inhibits its activity ([@B39]). Furthermore, H~2~S-induced *S*-sulfhydration could directly inhibit *S*-nitrosylation of eNOS to prevent eNOS from inactivation ([@B1]). Ohno and colleagues found that *S*-sulfhydration of PTEN at Cys71 and Cys124 by CBS/H~2~S could prevent its *S*-nitrosylation induced by NO and restore NO-caused PTEN inactivation under physiological conditions ([@B54]). However, Sun et al demonstrated that an increased *S*-nitrosylation level contributed to the additive myocardial postconditioning protection with H~2~S donor plus NO donor ([@B64]). Therefore, the interaction between S-nitrosylation and *S*-sulfhydration might be one kind of complicate communications between H~2~S-excited signaling and NO-induced signaling.

The relationship of *S*-sulfhydration and tyrosine nitration: The tyrosine nitration is a posttranslation modification by peroxynitrite and other reactive nitrogen species which happened at free tyrosine or protein tyrosine residues. Tyrosine nitration is regarded to partly mediate the cytotoxicity of reactive nitrogen species ([@B20]). [@B37] found that *S*-sulfhydration of SUR2B subunit of K~ATP~ channel at Cys 24 and Cys 2455 residues caused by H~2~S donor NaHS could prevent tyrosine nitration of Kir 6.1, another subunit of K~ATP~ channel, and K~ATP~ inactivation induced by peroxynitrite. Also, NaHS could decrease the calcium channel nitration and prevent the inhibitory effect of peroxynitrite in CaCl~2~-induced isolated mouse ileum contraction ([@B37]). The study demonstrates a new mechanism responsible for cytoprotective effect of H~2~S in reactive nitrogen species-induced injury and disease.

Methods For *S*-Sulfhydrated Protein Detection
==============================================

Establishing a detection method of protein *S*-sulfhydration has remained challenging for a long period. Scientists have investigated methods of detection to distinguish the persulfide group and free thiols. We here summarize the *S*-sulfhydration detection methods and discuss their advantages and the possible limitations in the experimental process (**Figure [3](#F3){ref-type="fig"}**).

![Reaction schemes of different methods for *S*-sulfhydraion detection. **(A)** biotin-switch assay; **(B)** cysteinyl labeling assay; **(C)** ➀ the maleimide assay, ➁ improved method of maleimide assay (Biotin-Thiol Assay) and ➂ protein persulfide detection protocol (ProPerDP); **(D)** ➀ tag-switch assay and ➁ new tag-switch assay; **(E)** mass spectrometry assay. MMTS: *S*-methyl methanethiosulfonate, Biotin-HPDP: *N*-\[6-(biotinamido)hexyl\]-3′-(2′-pyridyldithio) propinamide, IAA, Iodoacetic acid; DTT, dithiothreitol; IAP, Iodoacetamide-linked biotin; IAB, Iodoacetyl-PEG~2~-Biotin; MSBT, methylsulfonyl benzothiazole; CN-BOT, Cyanoacetic acid derivatives with the fluorescent BODIPY moiety; CN-Cy3, Cyanoacetic acid derivatives with the fluorescent Cy3-dye; IAM-Biotin, Iodoacetyl-PEG2-Biotin; TCEP, Tris(2-carboxyethyl)phosphine; IAM, Iodoacetamide; ACN, Acetonitrile; LC-MS/MS, Liquid chromatography and mass spectrometry.](fphar-08-00608-g003){#F3}

Biotin-Switch Assay
-------------------

The original method of *S*-sulfhydrated protein detection, named biotin-switch assay, was described by [@B49]. The authors simplified the original method of detecting nitrosylation for the specific cysteine thiol modification. In the first step, the thiol-blocking reagent MMTS is used to react with the -SH group. In the subsequent step, MMTS was removed by acetone, and persulfides were labeled with biotin-HPDP in dimethyl sulfoxide. Then, biotinylated proteins were pulled down by streptavidin-agarose beads, and then were washed with HENS buffer. For the last step, the biotinylated proteins were eluted by SDS-PAGE sample buffer and examined by western blot analysis. Mustafa and colleagues suggested that up to 25% proteins, especially in liver were sulfhydrated under basal conditions ([@B49]). *S*-sulfhydration is substantially more prevalent than nitrosylation and represents a previously unappreciated, major post-translational modification. Although this method is the first to identify *S*-sulfhydrated proteins, it has limitations. MMTS has been widely used in *S*-nitrosylation detection. The method for *S*-sulfhydrated group detection is based on the fact that the *S*-sulfhydrated protein does not react with MMTS as the prerequisite. However, in 2013, a study found that the -SH group could react with MMTS directly, which suggested that the biotin-switch assay was based on an incorrect chemical premise ([@B55]). The authors explained this phenomenon from the perspective of two mechanisms. First, MMTS may not block and alkylate all of the free thiols; the unblocked free thiols will then react with the pyridyldisulfide biotin reagent. Second, in the presence of a large number of free sulfhydryl groups unblocked in the first step, biotin labeling may be achieved by stepwise thiol--disulfide exchange. Hence, all the different situations that may result in the false-positive results of this method can be considered as not all the free sulfhydryl groups being completely blocked during the MMTS labeling step. Although this method has been in doubt and some other new methods were found later, many research teams also evaluated this method as sensitive and selective. New proteins that can be *S*-sulfhydrated were found by this original method ([@B48]; [@B42]).

Cysteinyl Labeling Assay
------------------------

In 2011, a new method based on a completely opposite principle of chemistry was used. The authors proposed that a new kind of thiol-blocking reagent, named IAA, would react with both *S*-sulfhydrated protein and free thiols ([@B39]). In the first step, desalting columns were pre-processed by IAA-free lysis buffer and then cell lysates were slowly passed through it. In the next step, DTT was applied to IAA-cleared lysates. During this phase, the authors proposed that the alkylated Cys residue, whether persulfide or another reversibly oxidized form, would reduce back to the thiolate state. So, at a last step, IAP was used to label the particular cysteine. The objection to this method is that it cannot distinguish persulfides from intramolecular, intermolecular and *S*-nitrosothiols, which will also be cleaved by DTT.

The Maleimide Assay, Biotin-Thiol-Assay and Protein Persulfide Detection Protocol
---------------------------------------------------------------------------------

[@B60] suggested a third method based on the chemical characteristics that *N*-ethyl maleimide (thiol-blocking reagent) would block both free thiol and persulfide. Cy5-conjugated maleimide was used in the first step and DTT in the second. The principle of this method is that the fluorescence signal decreases when the sample contains persulfides, and the decreased ratio of the fluorescence signal is the quantitative index ([@B60]). The limitation of this method is that it cannot be used widely for proteomic analysis.

A study in 2015 improved this method. The investigators made some changes to the experiment, named BTA ([@B24]). The authors used NM-Biotin to alkylate both cysteine residues or sulfhydrated cysteine in the first step. In the subsequent step, the avidin column was purified and eluted with DTT for cleaving the disulfide bonds; however, the biotin tag was still left bound to the column. The eluate from the column is further examined by western blot analysis. Furthermore, Dóka and colleagues described another new method named ProPerDP in early 2016. In the first step, IAB was used to alkylate both thiol and persulfide functional groups, but IAB would not discriminate and react with oxidized Cys residues in the original sample. In the second step, steptavidin-coated magnetic beads were used to pull down with alkylated proteins, with oxidized Cys residues maintained in the supernatant. In the last step, reducing buffer was used to re-suspend purified beads for cleaving the original persulfides as thiols selectively from steptavidin-coated magnetic beads, for the next step of determining persulfide proteins ([@B16]). The abovementioned two methods still have limitations. First, some proteins contain both sulfhydryl groups of the -SSH group and other non-persulfidated Cys residues. Therefore the protein that contains the -SSH group cannot cleave off from streptavidin beads in the last step, which would lead to false-negative signals. Second, the structure of disulfide bonds in intermolecular protein may result in false-positive persulfidated extra Cys residues on the polypeptide chains, which may also lead to false-positive signals. Third, to overcome the above-mentioned problem, a possible approach is to digest the alkylated protein before the pulldown step, because ensuring that the disulfide and free Cys moieties or persulfidated Cys would maintain the same form and in the same peptide is difficult.

Tag-Switch Assay
----------------

[@B88] proposed a new method to detect protein *S*-sulfhydrated that is based on the different physical and chemical properties between -SH and -SSH groups, named Tag-switch Assay ([@B88]). In the first step, a thiol-blocking reagent reacts with both free thiol and persulfide. The authors proposed that, compared with common disulfides in proteins, the disulfide bond in persulfide adducts might have a stronger reactivity to nucleophilicity. Then, a new tag-switching reagent was used to label persulfide protein only. This method has been accepted by some research teams ([@B56]; [@B94]). The main challenge for this new method is to ensure that the disulfide linkage in the -SSH group can express a specific and suitable nucleophile and then distinguish persulfide from free thiols. Treating cell lysates with dimedone was suggested to avoid any potential cross reaction ([@B56]).

[@B77] proposed to improve the original tag-switch method. The biotinylated cyanoacetic acid tag was used for the assay in the original tag-switch method, which requires western blot and unique antibodies for analyzing the final results. To increase the sensitivity, the authors synthesized two new kinds of cyanoacetic acid derivatives with the fluorescent BODIPY moiety (CN-BOT) for labeling cells and Cy3-dye (CN-Cy3) for labeling cell lysates. The improved tag-switch method for persulfide detection provides a new starting point for future researches to elucidate the actual mechanisms for H~2~S signaling pathway.

However, soon, some other chemists described the deficiencies of the tag-switch method. First, MSBT cannot penetrate the cell membranes, which poses an obstacle for the detection of persulfide in living cells. Besides that, in the "switching" step, methyl cyanoacetate was proposed to uniquely cut off MSBT-labeled dialkyl disulfides among the protein disulfide moieties. Nevertheless, selectivity was specific: it was only assessed on glutathionylated BSA and on the *N*-tert-butyloxycarbonyl derivatized cystine ([@B51]). Although the tag-switch method for persulfide detection is adopted by increasing numbers of research teams, as a new methodology, it also needs more trials to verify the true reliability and for comparison with previous methods.

Mass Spectrometry Assay
-----------------------

Most recently, [@B44] described details of mass spectrometry-based workflow for determining *S*-sulhydrated proteins and their sites. The proteins collected from cells were precipitated with trichloroacetic acid. The protein thiols and persulfides were labeled with IAMBio. After digestion of the proteins (Total), single peptides containing labeled persulfides or cysteines were concentrated and separated from non-cysteine peptides (flow through) through using streptavidin agarose beads. After several washes, persulfide-containing peptides were eluted by using TCEP with no effect on thiol-containing peptides. The subsequent accessible cysteines were labeled with iodoacetamide (Elution). As a control, labeled thiol peptides remaining on the beads were eluted by using 10 mM TCEP and 80% acetonitrile (Beads). Samples of the total, flow-through, elution and bead fraction were subjected to liquid chromatography and mass spectrometry and the peptides were identified by using PEAKS 7.0 proteomics software ([@B44]).

The Controversy of Sulfurated Modification
==========================================

Lately, investigators have discovered that a substance called polysulfide has cytoprotective effects also through mechanisms involving sulfurated modification of target proteins. The oxidation state of sulfur atom in thiol and H~2~S is -2. Atoms do not react with each other under the same oxidative state; therefore, H~2~S cannot sulfurate cysteine residues theoretically. The internal sulfur of H~2~S~n~ is 0. Therefore, it reacts with thiol readily ([@B38]). However, cysteine residues are oxidized to two main forms ---cysteine sulfenic acid or cysteine *S*-nitrosothiol --- under oxidative conditions. H~2~S shows a stronger ability to sulfurate these oxidized thiols than H~2~S~n~ ([@B36]; [@B38]). Therefore, when we verify target proteins that are thiolated, we should further verify and distinguish whether the sulfurated modification is due to H~2~S or H~2~S~n~. However, sulfurated modification, whether due to H~2~S or H~2~S~n~, is now well established. At present, the focus of the debate may lie in the specific process of -SSH, but it does not affect consensus on the important role of -SSH in various pathological and physiological processes. The balance between H~2~S and H~2~S~n~ plays a key role in controlling cellular metabolism.

Conclusion and Perspectives
===========================

With increasing studies concerning the effect of H~2~S on phenotype in physiological and pathological processes, the mechanism by which H~2~S functions in different signaling pathways via *S*-sulfhydration has gradually been recognized. *S*-sulfhydration is a new post-translational modification of proteins by H~2~S. From the beginning of this century, different research groups globally have found that many proteins can be modified by H~2~S via *S*-sulfhydration, but there are still a considerable amount of results did not link to the sulfhydration. Furthermore, we still need to elucidate the sites of *S*-sulfhydration that H~2~S acts on. Though some new views point out that polysulfides exert a cytoprotective effect, a lot of studies on the biological function of H~2~S remain. It is gratifying that a large number of laboratory experiments and clinical trials have revealed H~2~S to have a positive effect on the regulation of physiological and pathological processes and the inhibition of the disease progression. With better understanding of more proteins to be post-modified by H~2~S via *S*-sulfhydration, the biological protective effect of H~2~S will be well recognized.
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